Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

By Long N. Nguyen, Dongliang Ma, G. Shui, P. Wong, A. Cazenave-Gassiot, Xiaodong Zhang, Markus R. Wenk, E. Goh, D. Silver. Nature, 2014

930 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology (2017, background): “Although the mechanisms for DHA uptake into the brain had been enigmatic until recently, MFSD2A has been identified as the major transporter (52), as well as a negative regulator of transcytosis (53).”
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity (2020, background): “Major facilitator superfamily Essential omega-3 fatty acids, such as docosahexaenoic acid (DHA), are transported into the brain by the endothelial facilitator superfamily domain-containing protein 2a (MFSD2a) [149].”
The blood–brain barrier in health and disease: Important unanswered questions (2020, background): “Transport of glucose, lactate, amino acids, and fatty acids occurs via GLUT1 (Slc2a1), MCT1 (Slc16a1), LAT1 (Slc7a5), and MFSD2A, respectively (Boado et al., 1999; Cornford et al., 1994; Kido et al., 2000; Nguyen et al., 2014).”